AM
SBIOIntroducesNewReagentsforOrganoidGrowthandHarvestingHits:1196Date:5/6/2016AMSBIOhasintroducedtwonewproductstoassisttheincreasingnumberofscientistsadoptingorganoidcultureasaphysiologicallyrelevantmodelfororgandevelopment.
ThesenewtoolsbuilduponthewidespreaduseofAMSBIO’sBME2‘organoidmatrix’byle
ADIngresearchgroupsworldwide.BME2istheextracellularmatrixofchoiceforgrowingandsupportingorganoidculturesthatareincreasinglybeingadoptedindrugscreeningapplications.
AnewR-Spondin1celllinehasbeendevelopedthatprovidesacost-effectivesolutionbywhichlabscanobtainalong-termsupplyofR-Spondin1(RSPO1),whichisacriticalingredientusedinthemaintenanceandproliferationofmouseandhumanorganoid
Progenitorstemcells.R-SpondinspositivelyregulateWnt/beta-cateninsignaling,mostprobablybyactingasaligandforLGR4-6receptorsandaninhibitorforZNRF3.Our293TcelllineisstablytransfectedtoexpressmurineRSPO1withanN-terminalHAepitopetagandfusedtoaC-terminalmurineIgG2aFcfragmentAsaconsequencethiscelllinecanbeusedtoproduceeitherpurifiedRSPO1orRSPO1conditionedmedia.ThemurineRSPO1proteinfromthiscelllinehasbeendemonstratedtolowerthecostoforganoidcultureandtomaintainLgr5+stemcells.

AMSBIOhasalsointroducedaneworganoidharvestingsolutionthataddressesthechallengeofseparatingintactorganoidsfromextracellularproteinsinthehydrogelforpassaging,cryopreservation,orbiochemicalanalysis;andtofacilitatePDXxenograftmodels
Typicallyorganoidculturesexhibitcellularbehaviorsandmorphologiessimilartothoseseeninvivo.Unfortunately,adaptingthesemodelstostudybiochemicalprocesseshasbeenimpededbyproblemsassociatedwithseparatingintactorganoidsfromtheextracellularproteinsthatcomprisethehydrogel.Commonly,proteaseshavebeenemployedtodegradetheseextracellularproteins,butproteasetechniqueshavethedisadvantagesthattheyalsodegradeproteinsonthecellsurface,andthatproteaseactivitymaycarryoverintosubsequentculturesorlysatepreparations.TheCultrexOrganoidHarvestingSolutionfromAMSBIOprovidesanewnon-enzymaticmethodfordepolymerizingextracellularmatrixproteins,enablingharvestingofintactorganoidsfordownstreamapplications.
Forfurtherinformationonthesenewproductspleasevisithttp://www.amsbio.com/organoids.aspxorcontactAMSBIOon+44-1235-828200/+1-617-945-5033/info@amsbio.com.
Foundedin1987,AMSBiotechnology(AMSBIO)isrecognizedtodayasaleadingcompanycontributingtotheaccelerationofdiscoverythroughtheprovisionofcutting-edgelifesciencetechnology,productsandservicesforresearchanddevelopmentinthemedical,nutrition,cosmeticsandenergyindustries.AMSBIOisabletodrawuponin-depthexpertiseinextracellularmatricestoprovideelegantsolutionsforstudyingcellmotility,migration,invasionandproliferation.Widelyacknowledgedasanexpertincellculture,AMSBIOpartnerswithclientsintailoringcellsystemstoenhanceorganoidandspheroidtypescreeningoutcomesfromatechnologicalandcost-effectiveperspective.
---------------------
WorldwideHQ
AMSBiotechnology(AMSBIO)184MiltonPark
ABIngdonOxonOX144SEUK
Tel:+44-1235-828200
Fax:+44-1235-820482
Email:info@amsbio.com
Webwww.amsbio.comNorthAmericanHQAMSBIOLLC
1035CambridgeStreet
Cambridge
MA02141
USA
Tel:+1.617.945.5033
Tel:+1.800.987.0985(tollfree)
Email:info@amsbio.com
Webwww.amsbio.com